Categories: Tech

NYSE Content Advisory: Pre-Market Update + Evommune Rises in Trading Debut

NEW YORK, Nov. 7, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on November 7th

- Advertisement -
  • Equities are lower Friday morning after the major indices retreated Thursday in a volatile session. The S&P 500 shed 1.1% as signs of a cooling jobs market pushed down tech stocks and cryptocurrency.
  • Traders scooped up bonds amid bets that the Federal Reserve will cut interest rates due to a softening labor market. The Central Bank has one final meeting scheduled this year in Mid-December.
  • NYSE IPO’s Evommune and Grupo Aeromexico popped on their first day of trading yesterday. Evommune rallied 26% in its debut while Aeromexico rose 7.1%.


Opening Bell


PENCIL celebrates its 30th anniversary

- Advertisement -


Closing Bell


World Leaders in Data and AI (WLDA) celebrates the 2025 WLDA Summit

- Advertisement -


Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2817101/NYSE_Nov_7_Market_Update.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5609335/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–evommune-rises-in-trading-debut-302608704.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

1 day ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

7 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago